Intelligence Platform

Patents

Browse 783 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

US 6893869

Enhanced immune response to an antigen by a composition of a recombinant virus expressing

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue May 17 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6875433

Monoclonal antibodies and complementarity-determining regions binding to Ebola glycoprotei

The United States of America as represented by the Secretary of the Army · Granted Tue Apr 05 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 31 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6872398

Conjugate vaccine against gram-negative bacterial infections

The United States of America as represented by the Secretary of the Army · Granted Tue Mar 29 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6869787

Ricin vaccine and methods of making and using thereof

The United States of America as represented by the Secretary of the Army · Granted Tue Mar 22 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6869604

Recombinant anti-tumor RNAse

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Mar 22 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6869602

Method for treating, preventing, or inhibiting enterotoxigenic Escherichia coli infections

The United States of America as represented by the Secretary of the Army · Granted Tue Mar 22 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6855331

Sustained release hydrophobic bioactive PLGA microspheres

The United States of America as represented by the Secretary of the Army · Granted Tue Feb 15 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6855322

Isolation and purification of P. falciparum merozoite protein-142 vaccine

The United States of America as represented by the Secretary of the Army · Granted Tue Feb 15 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6852842

Methods for functional kidney imaging using small dendrimer contrast agents

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Feb 08 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6844010

Therapeutic treatment and prevention of infections with a bioactive materials encapsulated

The United States of America as represented by the Secretary of the Army · Granted Tue Jan 18 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6833132

Method of stimulating epithelial cells using keratinocyte growth factor (KGF) and method o

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 21 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6828309

Use of pentosan polysulfate to treat certain conditions of the prostate

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 07 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6825323

Compositions for treatment of hemorrhaging with activated factor VIIa in combination with

The United States of America as represented by the Secretary of the Army · Granted Tue Nov 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6815425

Pharmaceutical composition containing pGLU-GLU-PRO-NH2 and method for treating diseases an

The United States of America as represented by the Secretary of the Army · Granted Tue Nov 09 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6809184

Antibodies, including FV molecules, and immunoconjugates having high binding affinity for

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 26 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6797276

Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous i

The United States of America as represented by the Secretary of the Army · Granted Tue Sep 28 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6793927

Construction of Pasteurella haemolytica vaccines

The United States of America as Represented by the Secretary of the Department of Agriculture · Granted Tue Sep 21 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6787145

Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic meth

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Sep 07 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6770479

Anthrax vaccine

The United States of America as represented by the Secretary of the Army · Granted Tue Aug 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6756201

Diagnostic methods and gene therapy using reagents derived from the human metastasis suppr

The United States of America as represented by the Department of Health and Services · Granted Tue Jun 29 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6730498

Production of functional proteins: balance of shear stress and gravity

The United States of America as represented by the Administrator of the National Aeronautics and Space Administration · Granted Tue May 04 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6716450

Enhancing protein activity through nanoencapsulation

The United States of America as represented by the Secretary of the Army · Granted Tue Apr 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6713446

Formulation of boronic acid compounds

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Mar 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

US 6713444

Buforin I as a specific inhibitor and therapeutic agent for botulinum toxin B and tetanus

The United States of America as represented by the Secretary of the Army · Granted Tue Mar 30 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)